Maxx™
-
Biologics
Royal Biologics Announces FDA 510K Approval and U.S. Commercial Launch of the MAXX™-BMC Bone Marrow Aspirate Concentration System
June 1, 2022 – OrthoSpineNews – Royal Biologics (Hackensack, NJ) a company specializing on Advanced Cellular Technologies & Enhanced Autologous…
Read More » -
Biologics
Royal Biologics announces FDA Approval of the Maxx™ Concentration System.
HACKENSACK, NJ, September 7th, 2021 /OrthoSpineNews/ – Royal Biologics, an ortho-biologics company focused on Autologous and Live Cellular solutions has announced FDA…
Read More »